Literature DB >> 15104113

Compartmental inhibition of hepatic glutathione reductase activities by 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) in Sprague-Dawley and Fischer-344 rats.

Katrina S Jopperi-Davis1, Min Soo Park, Lynette K Rogers, Carl H Backes, In Kyoung Lim, Charles V Smith.   

Abstract

Administration of 1,3-bis(2-chloroethyl)-N-nitrosourea (BCNU) inhibits hepatic activities of glutathione reductase (GR) comparably in both adult male Fischer-344 (F344) and Sprague-Dawley (SD) rats in vivo. BCNU pretreatment greatly exacerbates the hepatic necrosis caused by diquat in F344 rats, but does not similarly potentiate liver injury in SD rats. The primary purpose of the present studies was to test the hypothesis that BCNU pretreatment would exhibit differences between the two strains in inhibition of GR activities in hepatic subcellular compartments that would correlate with the differing effects on diquat-induced hepatic necrosis. In the present studies, 16 h after administration of 80 mg/kg of BCNU, GR activities in the hepatic homogenates were 20-30% of activities in vehicle-treated controls. Neither the extents of inhibition nor the GR activities in hepatic cytosol, microsomes. mitochondria, or purified nuclei isolated by differential centrifugation were different between SD and F344 rats treated with BCNU. The results indicate that differences between SD and F344 rats in the effects of BCNU on susceptibilities to diquat-induced hepatic necrosis are not readily attributable to compartmentally selective inhibition of GR. In addition, hepatic O6-alkylguanine-DNA alkyltransferase (AGT, MGMT) levels were almost completely depleted in BCNU-treated rats of both strains, thus indicating that MGMT-dependent pathways are unlikely to be critical determinants of the effects of BCNU on this model of acute cell death mediated by reactive oxygen species in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104113     DOI: 10.1016/j.toxlet.2003.10.017

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  2 in total

1.  Riboflavin supplementation does not attenuate hyperoxic lung injury in transgenic (spc-mt)hGR mice.

Authors:  Kathryn M Heyob; Lynette K Rogers; Trent E Tipple; Stephen E Welty
Journal:  Exp Lung Res       Date:  2010-12-04       Impact factor: 2.459

2.  Glutathione reductase targeted to type II cells does not protect mice from hyperoxic lung injury.

Authors:  Kathryn M Heyob; Lynette K Rogers; Stephen E Welty
Journal:  Am J Respir Cell Mol Biol       Date:  2008-06-19       Impact factor: 6.914

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.